Contact this trialFirst, we need to learn more about you.
Dasatinib for Preventing Neuropathy in Gastrointestinal Cancer
Recruiting1 awardPhase 1
Columbus, Ohio
This trial is studying side effects and best dose of dasatinib to prevent damage to nerves caused by oxaliplatin in patients with gastrointestinal cancers receiving FOLFOX regimen.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.